Cullinan Therapeutics Balance Sheet (2020-2023) | CGEM

Balance Sheet Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023
Accumulated Depreciation 0.18M0.23M0.14M
Assets
Current Assets
Cash & Equivalents 168.20M293.54M123.67M445.40M59.77M314.90M611.00M576.00M156.15M390.70M491.80M466.40M
Prepaid Assets 2.07M6.42M7.76M7.79M6.10M7.46M11.85M6.12M7.18M8.33M6.44M10.28M
Current Assets 212.28M447.29M344.47M328.84M296.56M322.31M622.84M582.08M474.47M399.03M498.24M476.71M
Non-Current Assets
Property, Plant & Equipment (Net) 0.13M0.12M0.10M0.09M0.08M0.06M0.05M0.79M1.17M1.24M1.16M1.07M
Long-Term Investments 32.11M119.64M124.33M140.40M95.40M44.60M30.70M80.88M112.80M20.30M15.50M
Long-Term Deferred Tax 19.57M
Other Non-Current Assets 2.30M0.15M0.15M0.15M0.15M0.15M0.10M0.46M0.46M0.46M0.46M0.46M
Non-Current Assets 2.43M32.37M119.89M124.57M140.62M115.15M44.41M35.16M86.64M115.96M23.75M18.00M
Assets 214.71M479.67M464.35M453.40M437.19M437.46M667.25M617.24M561.12M514.99M521.98M494.71M
Liabilities
Current Liabilities
Accounts Payables 9.68M3.88M1.51M2.02M3.17M6.31M3.10M2.40M2.66M2.03M2.49M2.40M
Payables 9.68M3.88M1.51M2.02M3.17M6.31M3.10M2.40M2.66M2.03M2.49M2.40M
Accumulated Expenses 4.64M6.01M4.23M5.84M8.58M10.43M11.90M13.51M14.13M18.38M15.53M20.95M
Other Accumulated Expenses 0.97M1.96M
Current Leases 0.52M0.53M0.70M1.42M1.55M1.65M1.55M
Current Taxes 46.50M11.40M4.28M4.21M
Total Current Liabilities 14.32M9.89M5.74M7.86M11.75M17.26M62.03M27.12M22.50M26.17M19.68M23.44M
Non-Current Liabilities
Non-Current Deffered Revenue 0.07M0.07M0.07M0.07M0.07M
Minority Interest 1.30M2.80M2.99M2.09M0.40M0.77M0.08M
Operating Leases 0.74M0.60M3.99M3.59M3.17M2.73M2.45M
Total Liabilities 14.39M9.97M5.81M7.93M11.81M17.99M62.63M31.11M26.09M29.34M22.41M25.89M
Shareholder's Equity
Common Equity 200.31M469.70M458.54M445.47M425.37M419.47M604.62M586.13M535.03M485.65M499.57M468.82M
Shareholder's Equity 200.31M469.70M458.54M445.47M425.37M419.47M604.62M586.13M535.03M485.65M499.57M468.82M
Liabilities and Shareholders Equity 214.71M479.67M464.35M453.40M437.19M437.46M667.25M617.24M561.12M514.99M521.98M494.71M
Retained Earnings -93.34M-93.41M-109.05M-126.40M-158.91M-171.01M3.89M-20.91M-47.70M-105.66M-137.87M-177.05M
Treasury Shares 0.36M89.000.37M85.60M85.60M
Shares Outstanding 20.04M20.04M20.04M29.83M43.52M43.53M43.66M44.29M44.66M45.40M45.74M45.80M39.34M42.74M42.76M